Home
ADL Biopharma

ADL Biopharma Market Share Analysis for July 2026

ADL Biopharma, leader in precision fermentation biotechnology production, announced today its results for the year 2022.

Industry: N/A

Domainadlbiopharma.com

Year Founded1947

Employees201 - 500

Annual Revenue$50M - $75M

ADL Biopharma

ADL Biopharma (including company regionals)

adlbiopharma.com

See more website traffic and engagement information

ADL Biopharma Revenue up to July 2026 is 50M - 75M

revenue generated by ADL Biopharma top domains

ADL Biopharma top domains revenue over 3 years

Revenue for ADL Biopharma top domains

adlbiopharma.com50M - 75M

See more with Sales Intelligence

Total visits to ADL Biopharma's top domains

Understand ADL Biopharma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

adlbiopharma.com257

See more with Sales Intelligence

Avg. visit duration in ADL Biopharma's top domains

Analyze ADL Biopharma engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

adlbiopharma.com00:04:49

See more with Sales Intelligence

Avg. pageviews on ADL Biopharma's top domains

See how ADL Biopharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

adlbiopharma.com3.78

See more with Sales Intelligence

ADL Biopharma top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by ADL Biopharma

These are the website technologies, by industry, used by ADL Biopharma top domains

Widget (5)

Twemoji

Conversion & Analytics (4)

Google Analytics

Advertising (2)

DoubleClick

Mobile (2)

Meta Viewport

More Technologies

9

See all

News & Signals from ADL Biopharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAdl Biopharma attends event FELE awards event.In summary, the special mention awarded to ADL BioPharma and WACKER at the FELE awards event reflects its significant achievements in the industrial sector and its ongoing commitment to excellence and innovation in biotechnology.

NewsAdl Biopharma sold assets to Wacker Chemie AG on Jan 1st '16.In 2016, WACKER acquired from ADL BioPharma production assets with a fermentation capacity of 800 cubic meters (gross volume).

NewsWacker Chemie AG acquired Adl Biopharma for $110M on May 8th '23.Wacker Chemie said Monday that it has bought fermentation company ADL BioPharma for more than 100 million euros ($110.2 million).